ArticleCancer research communications2026

Targeting PRMT5 Inhibitor-Induced Adaptation in Pancreatic Cancer with the RBM39 Degrader Indisulam.

Valentina Spielmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.